Company intelligence / Profile preview

Woundchek Laboratories

Fall River, Massachusetts, United Stateswoundchek.com ↗

Ownership: Private
Development stage: Other

Overview

Woundchek Laboratories has developed and commercialized the world’s first point-of-care tests for detecting elevated protease activity and bacterial protease activity in chronic wounds. Clinical studies, including a multi-center Italian study, have shown that use of these diagnostics improves healing rates by enabling more targeted wound care interventions. The products are CE-marked and used in clinical practice internationally.

Therapeutic areas: Dermatology
Modalities: Device (point-of-care diagnostic test)In-vitro diagnostic test
Industry: Protein Biomarker Diagnostics

Partnerships

Distribution partners globally; specific names not disclosed publicly.

Beyond the preview

Go deeper on Woundchek Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Woundchek Laboratories.

Explore the full profile